Evidence map›Paper›PMID 15564498›Full record

ArticleJournal of virology2004

Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.

Fred W Peyerl, Heidi S Bazick, Michael H Newberg, Dan H Barouch, Joseph Sodroski, Norman L Letvin

Abstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 105 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Discovery immunology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Viruses · 2020
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fred W PeyerlHarvard Medical School, Beth Israel Deaconess Medical Center, Division of Viral Pathogenesis, Research East Room 113, 330 Brookline Ave., Boston, MA 02215, USA.
Heidi S Bazick
Michael H Newberg
Dan H Barouch
Joseph Sodroski
Norman L Letvin
Hadassah Medical Center · ILDana-Farber Cancer Institute · US

Funding

Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
IMMUNOREGULATION IN AIDSR01AI020729 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI LETVIN, NORMAN L · 1985 to 2008
$3.1M
IMMUNOREGULATION IN AIDSR37AI020729 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI LETVIN, NORMAN L · 1993 to 2002
$1.6M
NIAID NIH HHS AI-20729NIAID NIH HHS R01 AI020729NIAID NIH HHS R37 AI020729NIAID NIH HHS T32 AI007387NIAID NIH HHS T32-AI07387
6 · The paper itself

Abstract

The intense selection pressure exerted by virus-specific cytotoxic T lymphocytes (CTL) on replicating human immunodeficiency virus and simian immunodeficiency virus results in the accumulation of CTL epitope mutations. It has been assumed that fitness costs can limit the evolution of CTL epitope mutations. However, only a limited number of studies have carefully examined this possibility. To explore the fitness costs associated with viral escape from p11C, C-M-specific CTL, we constructed a panel of viruses encoding point mutations at each position of the entire p11C, C-M epitope. Amino acid substitutions at positions 3, 4, 5, 6, 7, and 9 of the epitope significantly impaired virus replication by altering virus production and Gag protein expression as well as by destabilizing mature cores. Amino acid substitutions at position 2 of the epitope were tolerated but required reversion or additional compensatory mutations to generate replication-competent viruses. Finally, while amino acid substitutions at positions 1 and 8 of the p11C, C-M epitope were functionally tolerated, these substitutions were recognized by p11C, C-M-specific CTL and therefore provided no selection advantage for the virus. Together, these data suggest that limited sequence variation is tolerated by the region of the capsid encoding the p11C, C-M epitope and therefore that only a very limited number of mutations can allow successful viral escape from the p11C, C-M-specific CTL response.

Indexed as

Point MutationVirus ReplicationAmino Acid SequenceAnimalsCapsid ProteinsCell LineEpitopes, T-LymphocyteGene Products, gagHIV-1HumansMacaca mulattaMolecular Sequence DataSequence AlignmentSimian Immunodeficiency VirusT-Lymphocytes, CytotoxicCapsid ProteinsEpitopes, T-LymphocyteGene Products, gag

Identifiers

PMID15564498
PMCPMC533946
OpenAlexW2158783859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.